Insider Transactions in Q1 2022 at Idex Corp (IEX)
Insider Transaction List (Q1 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 01
2022
|
Melissa S Flores SVP, CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
69
-7.6%
|
$13,179
$191.9 P/Share
|
Mar 01
2022
|
Lisa M Anderson SVP, General Counsel &Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
112
-7.35%
|
$21,392
$191.9 P/Share
|
Feb 25
2022
|
Stanfield Paris Watts Director |
BUY
Grant, award, or other acquisition
|
Direct |
155
+50.0%
|
$29,760
$192.49 P/Share
|
Feb 16
2022
|
Eric D Ashleman CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
7,368
-9.27%
|
$1,407,288
$191.27 P/Share
|
Feb 16
2022
|
Eric D Ashleman CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
16,611
+17.28%
|
$3,172,701
$191.27 P/Share
|
Feb 16
2022
|
William K Grogan Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,495
-15.25%
|
$476,545
$191.27 P/Share
|
Feb 16
2022
|
William K Grogan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,585
+25.45%
|
$1,066,735
$191.27 P/Share
|
Feb 16
2022
|
Denise R Cade SVP, General Counsel &Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
2,001
-16.4%
|
$382,191
$191.27 P/Share
|
Feb 16
2022
|
Denise R Cade SVP, General Counsel &Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct |
4,469
+26.81%
|
$853,579
$191.27 P/Share
|
Feb 16
2022
|
Daniel J Salliotte SVP, Corporate Development |
SELL
Payment of exercise price or tax liability
|
Direct |
749
-6.3%
|
$143,059
$191.27 P/Share
|
Feb 16
2022
|
Daniel J Salliotte SVP, Corporate Development |
BUY
Grant, award, or other acquisition
|
Direct |
1,631
+12.06%
|
$311,521
$191.27 P/Share
|
Feb 16
2022
|
Melissa S Flores SVP, CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
105
-10.37%
|
$20,055
$191.27 P/Share
|
Feb 16
2022
|
Melissa S Flores SVP, CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
301
+22.91%
|
$57,491
$191.27 P/Share
|